Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social Interactions: A Randomized-controlled Trial

NCT03553875 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT03553875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03553875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social Interactions: A Randomized-controlled Trial
Lead sponsor
Massachusetts General Hospital
Phase
Phase 3
Overall status
Terminated
Start date
November 13, 2018
Completion date
November 25, 2025
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism, autism spectrum disorder, nonverbal learning disability